CAPTRUST Financial Advisors’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
Other funds holding EBS
OHA
CAPTRUST Financial Advisors's EBS Position: Q2 2026 in Review
CAPTRUST Financial Advisors opened a new position in Emergent Biosolutions (EBS) in Q2 2026: 10,137 shares worth $84.9K. The stake represents ﹤0.01% of the portfolio and ranks #3071 among its holdings. This is a return to the name: CAPTRUST Financial Advisors previously reported a position in EBS as recently as Q2 2022.
CAPTRUST Financial Advisors first reported a position in EBS in Q4 2018 and has held it in 14 quarters since. The position peaked at $345K in Q4 2020. 195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.
- CAPTRUST Financial Advisors held 10,137 shares of Emergent Biosolutions worth $84.9K as of Q2 2026.
- Emergent Biosolutions was a new CAPTRUST Financial Advisors position in Q2 2026.
- Emergent Biosolutions made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #3071 holding.
- CAPTRUST Financial Advisors first reported a position in Emergent Biosolutions in Q4 2018 and has held it in 14 quarters since.
- CAPTRUST Financial Advisors's Emergent Biosolutions position peaked at $345K in Q4 2020.
- 195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.
Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.